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The joint injury is a common disorder. Some techniques have been employed to 
repair the joint or regenerate the cartilage defects with different degrees of success. 
Four commonly performed techniques to preserve the joint included osteotomies, 
bone marrow stimulation, cartilage repair, and cartilage regeneration.
Keywords: cartilage, articular/injuries, cartilage, articular/surgery,  
chondrocytes/transplantation, periosteum/transplantation, treatment outcome
1. Introduction
Musculoskeletal injuries that disrupt the structure and function of diarthrodial 
joints can cause permanent biomechanical alterations and lead to a more severe, 
chronic condition. Despite advancements that have been made of restore tissue 
function and delay the need for joint replacement, there are currently no disease-
modifying therapies for osteoarthritis (OA). To reduce the risk of OA, innovative 
preventive medicine approaches have been developed over the last decade to treat 
the underlying pathology.
The lesions of the articular cartilage are a common disorder that with the aging 
of the population its prevalence is increasing. More than 500,000 procedures are 
performed for the treatment of articular cartilage-related injuries, and many of 
these procedures are repeated in the same patients. This demonstrates the ineffec-
tiveness of this isolated procedure [1].
Hunter [2] noted that the cartilage, “once destroyed, is not repaired.” Fact that 
keeps current. Some studies have shown an incidence of cartilage lesions greater 
than 65% in routine arthroscopy [3–6]. No procedure nowadays is reliable for the 
regeneration of articular cartilage. This is due to the complexity of its structure 
and functional properties, such as minimizing friction and increasing the contact 
surface area to decrease wear under load.
Cartilage lesions (9 mm or greater) have been reported to be biomechanically 
unstable with a high propensity of progression to degenerative osteoarthritis [7, 8]. 
The main characteristics of the clinical presentation are pain, loss of movement, 
and alteration of function. Various surgical procedure options can be used for treat-
ment; this will depend on the location, size, and stage [9, 10].
Articular cartilage is composed of chondrocytes (5–10%), water (65–80%), col-
lagen, smaller glycoproteins such as fibronectin and oligomeric cartilage proteins, 
and large negatively charged hydrophilic proteoglycans (aggrecan, hyaluronan). 
Four distinct zones are described microscopically.
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The superficial zone protects the deeper layers of shear stresses and composes 
approximately 10–20% of the thickness of the articular cartilage. The main collagen 
fibers found are type II and IX with a high number of flat chondrocytes. It is the layer 
that protects and maintains the integrity of the deeper layers, is in direct contact with 
the synovial fluid, and is responsible for most of the traction properties of the cartilage, 
which allows it to resist the pure, elastic, and compressive forces imposed by the joint.
The intermediate (transitional) zone provides an anatomic and functional 
bridge between the superficial and deep zones, accounts for 40–60% of the total 
cartilage volume, and contains thicker collagen proteoglycans and fibrils. Collagen 
is organized obliquely, and the chondrocytes are spherical and low density. The 
compressive forces mainly exhibit resistance.
The deep zone is responsible for providing greater resistance to the compressive 
forces, since the collagen fibrils are arranged perpendicular to the articular surface. 
The deep zone contains collagen fibrils of larger diameter in radial arrangement, 
higher content of proteoglycans, and lower concentration of water. Chondrocytes are 
typically arranged in columnar orientation, parallel to collagen fibers, and perpendicu-
lar to the joint line. It represents approximately 30% of the articular cartilage volume.
The calcified layer plays an integral role in the attachment of the cartilage to the 
bone, anchoring the collagen fibers from the deep zone to the subchondral bone. 
There are few cells and the chondrocytes are hypertrophic [9, 11–13].
Several factors are part of the etiology of the chondral or osteochondral lesion; 
among them are metabolic, such as obesity, alcohol abuse, and diabetes, as well as 
mechanical factors such as trauma, joint misalignment, and instability [12, 13].
Osteochondral lesions heal by formation of fibrocartilage secondary to the 
initial inflammatory response. Although mesenchymal cells produce collagen type 
I and II, the repair is mostly fibrocartilaginous in nature. The orderly structural 
organization of normal hyaline cartilage is lacking and results in early degradation 
and fragmentation. However, pure chondral lesions are painless and poorly repaired 
due to lack of vascularity [9, 14].
Surgical and nonoperative procedures are employed in the treatment of cartilage 
lesions. The main objective goal is to reduce pain and restore function. Nonsurgical 
treatments include physical therapy, activity modification, braces and orthoses, 
weight loss, steroid injections, chondroitin sulfate, and viscosupplementation with 
hyaluronic  preparations [15–20]. The operative treatment aims to improve joint func-
tion and congruence as well as prevent osteoarthritic damage in intact areas of car-
tilage. It may be divided into three techniques commonly performed to preserve the 
joint including bone marrow stimulation, cartilage repair, and cartilage regeneration.
2. Bone marrow stimulation (BMS) techniques
2.1 Drilling/microfracture/abrasion techniques
Burmann in 1931, Haggart in 1940, and Magnuson in 1941 described joint 
debridement techniques for the treatment of osteoarthritis. Pridie in 1958 intro-
duced the technique of perforation of the subchondral tissue exposing the vascu-
larization of bone marrow, and later Ficat in 1979 described the spongialization, a 
resection of the entire subchondral bone plate chondromalacia patellae, with good 
to excellent results. Steadman suggested that specially designed awls are used to 
make multiple perforations or “microfractures,” into the subchondral bone plate 
[21–30]. The perforations are made as close together as necessary, but not so close 
that one breaks into another. Consequently, the microfracture holes are approxi-
mately 3–4 mm apart (or three to four holes per square centimeter) [31, 32].
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Chondroplasty by abrasion depends on the mechanical stimulation, like burrs, 
of the joint defect, without penetration of the subchondral bone. Exposure of small 
blood vessels generates formation in a clot attached to the surface. Fibrous tissue 
metaplasia occurs for fibrocartilage.
Multiple perforations have the benefit of causing less thermal damage than 
chondroplasty by abrasion and also leave the subchondral surface more rugged, 
allowing better adhesion of the blood clots. The penetration of the subchondral 
bone stimulates the local release of growth factors from the underlying bone. These 
factors attract and aid the differentiation of mesenchymal stem cells from the bone 
marrow in chondrocyte-like cells [33, 34].
Patients require a period of 6–8 weeks of non-weight-bearing to allow matura-
tion of the fibrocartilage. Also, according to some authors, continuous passive 
motion for pain control and better function may be necessary [35].
For better results, some important factors include a body mass index below 
30 kg/m2, age under 40 years, defect less than 4 cm2, volume of repaired cartilage 
(defective filling) greater than 66%, and symptoms less than 12 months [35].
The repair tissue may be able to fill the defect, but it lacks the normal histological 
or biomechanical properties of hyaline cartilage. Therefore, it has a stability inferior 
to the compressive and shear forces and tends to deteriorate with the time [35–39].
However, in their 2017 study, Frehner et al. concluded that treatment of osteo-
chondral lesion by microfracture cannot be seen as an evidence-based procedure [39].
3. Cartilage replacement techniques
3.1 Chondrocyte autograft transfer and mosaicplasty
The description of the technique using osteochondral autografts for the treat-
ment of joint defects was firstly studied by Pap and Krompecher [40]. Later, 
Wagner and Muller in Germany used the posterior part of the femoral condyle as an 
osteochondral autograft [41, 42]. Motions came in the 1990s by Matsusue in Japan 
and Hangody and colleagues in Hungary [43, 44].
The osteochondral plugs are harvested from non-weight-bearing areas and 
are transplanted into a small osteochondral defect. A larger lesion is filled in with 
multiple cylinders; it is also possible to transfer the posterior femoral condyle. 
Due to multiple cylinders, the gaps between the plugs produce an irregular 
articular surface.
The main indications for mosaicplasty include the chondral or focal osteochon-
dral lesion in a stable knee, with lesions smaller than 22 mm in diameter and no 
more than 10 mm in depth.
The main benefits of this technique are that it is a single-stage procedure and 
there is rapid subchondral bone healing with restoration of native type II hyaline 
cartilage at the articular surface.
In a series by Hangody et al. with 57 patients and follow-up of more than 3 years, 
reported 91% good to excellent results with a mosaicplasty [45]. Gudas et al. in a 
prospective randomized study showed better clinical-functional and MRI results 
after 3 years for osteochondral transplants than for microfracture surgery [46].
Most of the studies showed good to excellent results in the short and long term, 
with a greater return to athletic activity when compared to microfracture [47–54].
Major complications of the osteochondral graft include donor site morbidity 
such as patellofemoral arthritis, fibrocartilage hypertrophy of the donor area, 
and unsatisfactory filling of the cartilage defect (especially with grafts > 8 mm in 
diameter) [49, 52, 54–56].
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3.2 Osteoperiosteal graft
Another option we have for the treatment of osteochondral lesions is the 
mosaicplasty technique with bone-periosteum graft of the iliac crest. Its two 
advantages compared to the conventional technique include the absence of 
joint morbidity from the donor site defect [54] and that the periosteum (with 
its pluripotent stem cells) has the potential to differentiate into fibrocartilage 
[56–63].
3.2.1  Reconstruction with periosteal-cortical graft of the tibial lateral plateau: 
clinical outcome with an 18-month follow-up case
A 63-year-old woman presented with a bicondylar fracture of the right tibial 
plateau with extension to the diaphysis. She underwent surgical treatment 40 days 
after the fracture. It presented great destruction of the lateral articular surface, 
being reconstructed with the use of periosteal cortical graft of the external iliac 
board, suture of lateral meniscus, and reinsertion. Fixation of the graft with 
Kirschner wire and cortical screw is associated with lateral support plate and medial 
locked plate (Figures 1–4).
3.2.2 Cartilage regeneration techniques
3.2.2.1 Osteochondral allograft case 1
A 45-year-old male presented to us with 1 year of posteromedial right ankle 
pain. He reported pain related to physical activities, with a history of previous 
trauma, swelling of the joint, no feeling of instability, or joint blockage. Physical 
examination showed diffuse tenderness of the joint during maximal flexion and 
areas sensitive to touch in the medial tibiotalar joint line with negative ankle stabil-
ity test (Figures 5 and 6).
The patient did not show good evolution with nonoperative treatment; a mosa-
icplasty with medial malleolus osteotomy was indicated (Figures 7–11).
The patient progressed well and returned the physical activities, including run-
ning without pain in the 6 month postoperatively.
Figure 1. 
Image arrival to the service.





An 18th month of evolution.
Figure 4. 
Final result.
Cartilage Tissue Engineering and Regeneration Techniques
6
Figure 6. 
Osteochondral lesion contained in zone 7 of Raikin.
Figure 7. 
A osteochondral lesion on the talar medial shoulder after osteotomy of the medial malleolus.
Figure 5. 
Osteochondral lesion with cystic formation in the domus talar medialis measuring 1.0 × 0.7 × 0.7 cm, 
surrounded by area of bone edema. Stage V by Berndt & Harty.
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Figure 8. 
Intraoperative image of cartilage defect removal.
Figure 9. 
Removal of the cylinder from the lateral superior region of the femoral trochlea (donor area).
Figure 10. 
Osteochondral cylinders inserted perpendicularly to the receiving surface.




4. Cartilage regeneration techniques
4.1 Autologous chondrocyte implantation (ACI)
The technique initially described by Brittberg in 1994 nowadays is the most 
used for cartilage regeneration [60]. ACI is a two-stage procedure; arthroscopy is 
initially performed to evaluate the lesion, and three to four CA chondral biopsies 
are taken from non-weight-bearing surfaces of the joint (intercondylar notch, 
peripheral edges of the femoral condyles). The sample is then sent to the labora-
tory, where chondrocytes are isolated with an enzymatic process. The chondrocytes 
are then cultured for 3–4 weeks until the volume increases by 30 times for implan-
tation (12 million chondrocytes approx.). Usually, after 6 weeks of the initial 
surgery, the second procedure is performed [59–66].
4.1.1 First generation
Access with medial or lateral patellar arthrotomy is performed in association 
with defect debridement. A periosteal flap is removed from the proximal region 
of the tibia or medial femoral condyle. The flap is then attached to the defect 
(with its cambium layer facing the bone) on all sides, except at the top. The 
cultured chondrocytes are then injected under the flap, and, finally, the flap is 
then attached superiorly as well. The fibrin glue can be used to seal the edges of 
the flap [60].
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4.1.2 Second generation
Due to complications arising from calcifications, the periosteum was replaced by 
a reabsorbable collagen membrane [66].
4.1.3 Third generation
The modification is the cultivation of the articular cells directly on a surface of a 
membrane-like MACI or cells grown within a scaffold [67].
4.1.4 Surgical technique
This procedure is a two-stage technique in which an arthroscopic approach is 
performed to evaluate the lesion and second used to harvest a sample of normal 
articular cartilage from a non-weight-bearing region of the knee. Chondrocytes 
are then isolated, cultured, and seeded onto a hyaluronan-based scaffold or 
collagen. The chondrocytes are then cultured for 3–4 weeks until the volume 
increases by 30 times for implantation, the second stage of the procedure 
arthrotomy to implant the scaffold in the lesion site. The chondral defect is 
prepared and is then used to shape the scaffold, which is pressed into the lesion 
site and secured with a thin layer of fibrin glue. The graft is assessed for stability 
before the wound is closed.
The best postoperative rehabilitation protocols are those of 6 weeks, starting the 
first 2 weeks with a partial load of 20% of body weight, followed by a progressive 
increase to a full load at 6 weeks postoperatively [67–73].
5. Conclusion
The articulations in their particularities refine the movement and enable a series 
of domains and skills of great importance for the development of human activities.
Thus, there is a growing interest in achieving more promising techniques in joint 
maintenance through cartilage repair. Some more modern techniques, involving the 
development and application of stem cells or the use of vectors to carry chondro-
cytes to the target lesion, still lack more consistent evidence in the long term that 
can justify their costs. Techniques that employ older, established concepts, such as 
microfracture and abrasion arthroplasties, are more accessible but fail to maintain 
their initial results over the years.
In this way, the development of a less invasive technique, aimed at preserv-
ing joint functions and minimizing symptoms, with sustainable durability and 
feasible cost, continues to guide the search for innovations in the arid terrain of 
joint preservation.
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